USPTO 2015–2025 USPTO PatentsView US Corporation

Idexx Laboratories Inc.

USPTO PatentsView assignee record — 91 granted patents across 33 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES).

91
Total patents granted
33
CPC technology areas
18.8
Avg claims per patent
+114%
5-year filing velocity

The verdict

Idexx holds 91 US patents across 33 technology areas — rank #3,969 of 50,000 tracked assignees.

#3,969
of 50,000 US assignees by volume
Top 5%
by Innovation Score (57.2/100)
18.8
avg claims per patent
+114%
filing velocity, last 5 yrs

Portfolio overview

IDEXX LABORATORIES INC. has been granted 91 US utility patents between 2015 and 2025, placing IDEXX LABORATORIES INC. at rank #3,969 across all assignees tracked by PlainPatent. This portfolio spans 33 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.8 claims per patent with primary concentration in G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES). As a US Corporation, IDEXX LABORATORIES INC. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 57.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 62 grants, compared with 29 in the 2015–2019 window — a +114% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. IDEXX LABORATORIES INC.'s 18.8 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 33 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark IDEXX LABORATORIES INC. against peers pursuing similar technology classes.

How does IDEXX compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows IDEXX holds 91 patents — placing it at rank #3,969 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

IDEXX's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

57 Top 5% higher than 95% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView — PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

05101520 20152016201720182019202020212022202320242025 16
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
IDEXX LABORATORIES INC. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 15 16.5%
2016 4 4.4%
2017 4 4.4%
2018 2 2.2%
2019 4 4.4%
2020 8 8.8%
2021 8 8.8%
2022 6 6.6%
2023 9 9.9%
2024 15 16.5%
2025 16 17.6%

Which technologies does IDEXX LABORATORIES INC. patent most?

Top 15 of 33 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Accelerating

Where it ranks

Overall rank by patents

#3,969

Across all tracked assignees

Innovation Score

57.2 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does IDEXX LABORATORIES INC. hold?
IDEXX LABORATORIES INC. holds 91 US granted patents filed between 2015 and 2025, spanning 33 technology areas.
What is IDEXX LABORATORIES INC.'s Innovation Score?
IDEXX LABORATORIES INC. has an Innovation Score of 57.2 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does IDEXX LABORATORIES INC. focus on?
IDEXX LABORATORIES INC.'s top technology area is G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES) with 70 patents. The company has filed patents in 33 CPC subclasses total.
Is IDEXX LABORATORIES INC.'s patent filing rate increasing or decreasing?
IDEXX LABORATORIES INC.'s recent filing velocity is +114% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for IDEXX LABORATORIES INC.'s patents?
IDEXX LABORATORIES INC.'s patents average 18.8 claims each. This falls within the standard range, providing solid legal coverage.
How is the IDEXX LABORATORIES INC. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

How to use this portfolio

Idexx's 91 grants land it in the top 5% by Innovation Score — but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance — Idexx ranks #3,969 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in G01N — see who else leads that technology area. G01N leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity — not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Data sources used on this page
  • USPTO PatentsView — the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) — the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search — the official interface to verify the status of any individual patent. ppubs.uspto.gov